SE462419B - Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar - Google Patents

Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar

Info

Publication number
SE462419B
SE462419B SE8303700A SE8303700A SE462419B SE 462419 B SE462419 B SE 462419B SE 8303700 A SE8303700 A SE 8303700A SE 8303700 A SE8303700 A SE 8303700A SE 462419 B SE462419 B SE 462419B
Authority
SE
Sweden
Prior art keywords
hda
injection
animals
cardiovascular diseases
treatment
Prior art date
Application number
SE8303700A
Other languages
English (en)
Swedish (sv)
Other versions
SE8303700D0 (sv
SE8303700L (sv
Inventor
H Ohnishi
K Yamaguchi
Y Suzuki
N Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8303700D0 publication Critical patent/SE8303700D0/xx
Publication of SE8303700L publication Critical patent/SE8303700L/xx
Publication of SE462419B publication Critical patent/SE462419B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D315/00—Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8303700A 1982-06-28 1983-06-28 Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar SE462419B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57111183A JPS591415A (ja) 1982-06-28 1982-06-28 循環系疾患治療剤

Publications (3)

Publication Number Publication Date
SE8303700D0 SE8303700D0 (sv) 1983-06-28
SE8303700L SE8303700L (sv) 1983-12-29
SE462419B true SE462419B (sv) 1990-06-25

Family

ID=14554592

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303700A SE462419B (sv) 1982-06-28 1983-06-28 Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar

Country Status (11)

Country Link
US (1) US4578400A (nl)
JP (1) JPS591415A (nl)
AU (1) AU546935B2 (nl)
CA (1) CA1209921A (nl)
CH (1) CH660556A5 (nl)
DE (1) DE3323264C2 (nl)
FR (1) FR2529081B1 (nl)
GB (1) GB2123691B (nl)
IT (1) IT1173725B (nl)
NL (1) NL187299C (nl)
SE (1) SE462419B (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665737B2 (ja) * 1986-05-27 1997-10-22 宇部興産株式会社 微粒子状無機フイラー分散液の製造法
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US8334135B2 (en) * 2002-07-31 2012-12-18 Yves Saint Laurent Parfums Stem cells from adipose tissue, and differentiated cells from said cells
ATE482698T1 (de) * 2003-06-18 2010-10-15 Inst Cardiologie De Montreal M Vermeidung von vorhofflimmern (af) mit der verwendung von statin
DE102004052697A1 (de) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation
US8722734B2 (en) * 2005-03-02 2014-05-13 Merck Sharp & Dohme Corp. Composition for inhibition of cathepsin K
DE102006019906A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptable Salze zur Herstellung einer pharmazeutischen Zubereitung
JP5469781B1 (ja) * 2012-03-27 2014-04-16 辻本化学工業株式会社 ＰＰＡＲｓアゴニスト活性亢進薬
JP7193471B2 (ja) * 2017-04-10 2022-12-20 ヴィタフロ （インターナショナル） リミテッド てんかんの治療に使用するための組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417119A (en) * 1972-11-30 1975-12-10 Thiele G H Process for treating bones
US4225501A (en) * 1977-07-25 1980-09-30 Givaudan Corporation 1,4-Epoxy-1,3,3-trimethyl-2-(2-buten-1-ylidene)-cyclohexanes
US4357315A (en) * 1980-08-07 1982-11-02 International Flavors & Fragrances Inc. Use of 1-ethoxy-1-ethanol acetate for augmenting or enhancing the taste of toothpaste

Also Published As

Publication number Publication date
CH660556A5 (de) 1987-05-15
FR2529081A1 (fr) 1983-12-30
IT8348588A0 (it) 1983-06-28
SE8303700D0 (sv) 1983-06-28
DE3323264C2 (de) 1986-03-06
AU1631583A (en) 1984-01-05
GB2123691B (en) 1985-07-31
JPS591415A (ja) 1984-01-06
FR2529081B1 (fr) 1985-11-15
NL187299B (nl) 1991-03-18
GB8317357D0 (en) 1983-07-27
GB2123691A (en) 1984-02-08
US4578400A (en) 1986-03-25
DE3323264A1 (de) 1984-01-05
IT1173725B (it) 1987-06-24
AU546935B2 (en) 1985-09-26
JPH0142246B2 (nl) 1989-09-11
NL8302273A (nl) 1984-01-16
CA1209921A (en) 1986-08-19
SE8303700L (sv) 1983-12-29
NL187299C (nl) 1991-08-16

Similar Documents

Publication Publication Date Title
US4613593A (en) Therapeutic and preventive agent containing dolichol
JPH02108636A (ja) 抗腫瘍性組合せ製剤
DE2726618A1 (de) Allylcarbonsaeure-ester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2710327C3 (de) Verwendung von Benzaldehyd
SE462419B (sv) Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar
RU2268727C2 (ru) Лекарственное средство, обладающее защитным действием в отношении окислительно-токсических и прежде всего кардиотоксических соединений
JPS60132921A (ja) ホスファチジルセリン医薬組成物
DE2923009A1 (de) Mittel zur prophylaxe und behandlung der fibrose
HU201672B (en) Process for producing pharmaceutical compositions comprising podophyllotoxin
JP3075358B2 (ja) 肝機能改善剤
EP1140113A2 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
EP0207097B1 (de) Neue kohlensäureester
EP0509042B1 (de) Intravenös applizierbare Pharmazeutische Zubereitung von 1-Octadecyl-2-methyl-glycero3-phosphocholin
WO2012056976A1 (ja) アデニル酸シクラーゼの活性調節剤
EP0121856A2 (de) Verwendung von Pyrazolonderivaten bei der Bekämpfung des Wachstums von Tumorzellen und der Metastasenbildung, Arzneimittel hierfür und Verfahren zu deren Herstellung
US4603126A (en) Therapeutic and preventive agent containing dolichol
EP0149847A2 (en) Therapeutic and preventive agent containing dolichol
US6057308A (en) Remedy or preventive for hyperlipemia
US4599328A (en) Therapeutic and preventive agent containing dolichol
US4791105A (en) Therapeutic and preventive agent containing dolichol
Wagner et al. Pharmacokinetics and bioavailability of oral ifosfamide
EP0653206A1 (en) Anti-hiv agent
US3749781A (en) Pharmaceutical composition and method of treatment
DE2515142A1 (de) Mittel zur prophylaxe von artheriosklerose
US3824315A (en) Method of treatment

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8303700-2

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8303700-2

Format of ref document f/p: F